Key result
Streptokinase therapy in acute major pulmonary embolism led to angiographic improvement in 75% of evaluated patients, compared to 0% in those treated with heparin.
Why the study?
Does streptokinase improve clinical and angiographic outcomes in patients with acute major pulmonary embolism?
Observational (n=21)
Does streptokinase improve clinical and angiographic outcomes in patients with acute major pulmonary embolism?
Streptokinase therapy hastens early angiographic and clinical resolution in acute major pulmonary embolism, particularly when administered shortly after a single embolic episode.
Answers are grounded in this paper and cite their sources.
Streptokinase may accelerate resolution in major PE; leaves open superiority over heparin pending randomized trials.
Eighteen patients with major pulmonary embolism were treated with streptokinase infused by a catheter or given intravenously. Fourteen showed clinical improvement and 12 out of 16 patients investigated showed definite angiographic improvement after 24 to 48 hours of treatment with streptokinase. The angiographic improvement following streptokinase contrasted with the lack of this in three patients after 24 hours of heparin treatment.Resolution following streptokinase therapy was most noticeable in patients treated shortly after a single embolic episode, and was least marked in those with recurrent embolism complicated by associated cardiac or pulmonary disease. Of the four patients who failed to improve, two died and two had pulmonary embolectomy and survived.The results suggest that streptokinase therapy is practicable provided that adequate laboratory control is available, and that it hastens early resolution in acute major pulmonary embolism.
No takes yet. Share an insight, caveat, or question.
Hirsh et al. (1968) conducted an observational in Acute major pulmonary embolism (n=21). Streptokinase vs. Heparin was evaluated on Angiographic improvement. Streptokinase therapy in acute major pulmonary embolism led to angiographic improvement in 75% of evaluated patients, compared to 0% in those treated with heparin.
Synapse has enriched 10 related papers. Consider them for comparative context: